Shepherd Financial Partners LLC Eli Lilly & CO Transaction History

Shepherd Financial Partners LLC

$826 Million
Q3 2024

A detailed history of Shepherd Financial Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Shepherd Financial Partners LLC holds 11,162 shares of LLY stock, worth $8.88 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

11,162

Previous 10,932 2.1%

Holding current value

$8.88 Million

Previous $9.9 Million 0.09%

% of portfolio

1.2%

Previous 1.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$772.14 - $960.02 $177,592 - $220,804	230 Added 2.1%	11,162 $9.89 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $28,269 - $35,452	39 Added 0.36%	10,932 $9.9 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $134,429 - $179,847	-227 Reduced 2.04%	10,893 $8.47 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $30,986 - $36,528	-59 Reduced 0.53%	11,120 $6.48 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $71,290 - $98,285	-164 Reduced 1.45%	11,179 $6 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $107,326 - $143,507	306 Added 2.77%	11,343 $5.32 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $15,531 - $18,241	50 Added 0.46%	11,037 $3.79 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $8,360 - $9,741	-26 Reduced 0.24%	10,987 $4.02 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $570,724 - $650,399	-1,925 Reduced 14.88%	11,013 $3.56 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $265,072 - $311,233	-951 Reduced 6.85%	12,938 $4.2 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $78,386 - $97,414	334 Added 2.46%	13,889 $3.98 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.44 Million - $1.79 Million	6,400 Added 89.45%	13,555 $3.74 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $9,307 - $11,453	-42 Reduced 0.58%	7,155 $1.65 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $90,275 - $116,770	500 Added 7.47%	7,197 $1.65 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $62,112 - $80,408	378 Added 5.98%	6,697 $1.25 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $34,832 - $46,092	267 Added 4.41%	6,319 $1.07 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $7,457 - $8,625	-51 Reduced 0.84%	6,052 $896,000
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $7,775 - $9,358	-57 Reduced 0.93%	6,103 $1 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $29,167 - $36,100	245 Added 4.14%	6,160 $856,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $11,440 - $14,170	107 Added 1.84%	5,915 $778,000
Q3 2019 Nov 25, 2019	SELL	$106.79 - $116.16 $70,267 - $76,433	-658 Reduced 10.18%	5,808 $646,000
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $40,881 - $47,719	-369 Reduced 5.4%	6,466 $716,000
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $142,365 - $167,574	-1,279 Reduced 15.76%	6,835 $887,000
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $170,393 - $190,891	-1,609 Reduced 16.55%	8,114 $938,000
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $28,690 - $32,927	-379 Reduced 3.75%	9,723 $831,000
Q1 2018 May 01, 2018	SELL	$74.21 - $87.6 $19,146 - $22,600	-258 Reduced 2.49%	10,102 $782,000
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $245 - $263	-3 Reduced 0.03%	10,360 $874,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $798,676 - $886,451	10,363	10,363 $899,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Financial Partners LLC with notifications on news.

Account

Shepherd Financial Partners LLC Eli Lilly & CO Transaction History